Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea

被引:3
|
作者
Kwon, Yu-Jin [1 ]
Choi, Ja-Eun [2 ]
Hong, Kyung-Won [2 ]
Lee, Ji-Won [3 ,4 ]
机构
[1] Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Family Med, 363 Dongbaekjukjeon Daero, Yongin 16995, Gyeonggido, South Korea
[2] Theragen Hlth Co Ltd, Inst Adv Technol, Pangyoyeok Ro, Seongnam 13493, Gyeonggido, South Korea
[3] Yonsei Univ, Coll Med, Severance Hosp, Dept Family Med, Yonsei Ro 50-1, Seoul 03722, South Korea
[4] Yonsei Univ, Inst Innovat Digital Healthcare, Yonsei Ro 50-1, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
Mediterranean diet; Metabolic dysfunction-associated fatty liver disease; Gene-diet interaction; Glucokinase regulatory protein gene; FATTY LIVER; TRIGLYCERIDE; VALIDATION; OBESITY; LOCI; GCKR;
D O I
10.1186/s12967-024-05408-z
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Backgrounds Metabolic dysfunction-associated steatotic liver disease (MASLD) has gained attention owing to its severe complications. This study aimed to explore the interaction between Mediterranean-diet (MD) adherence, genetic factors, and MASLD risk in a Korean population. Methods In total, 33,133 individuals aged 40 years and older from the Korean Genome and Epidemiology Study (KoGES) were analyzed. Participants were assessed for MASLD based on criteria and MD adherence measured by the Korean version of the Mediterranean-Diet Adherence Screener (K-MEDAS). Individuals were categorized into two groups based on their MD adherence: high adherence (K-MEDAS > 6) and low adherence (K-MEDAS < 5). Single nucleotide polymorphism (SNP) genotypes were obtained using the Korea Biobank array. Logistic regression was used to examine the single-marker variants for genetic associations with MASLD prevalence. Results Individuals were categorized into MASLD (10,018 [30.2%]) and non-MASLD (23,115 [69.8%]) groups. A significant interaction was observed between the rs780094 glucokinase regulatory protein (GCKR) gene and K-MEDAS on MASLD (p < 10(-2)). Of individuals with K-MEDAS > 6, those carrying the minor allele (C) of the GCKR gene rs780094 exhibited a lower risk of MASLD compared to those without the allele (odds ratio [OR] = 0.88 [0.85-0.91], p-value = 5.54e-13). Conclusion The study identified a significant interaction involving the rs780094 variant near the GCKR gene, with carriers of the minor allele exhibiting a lower MASLD risk among those adhering well to the MD. Dietary habits influence the MASLD risk associated with the rs780094 allele, emphasizing the need for personalized nutrition recommendations.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
    Zheng, Haixiang
    Sechi, Leonardo Antonio
    Navarese, Eliano Pio
    Casu, Gavino
    Vidili, Gianpaolo
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [32] Metabolic dysfunction-associated steatotic liver disease and cancer risk: A cohort study
    Peng, Yu
    Wang, Peng
    Liu, Fubin
    Wang, Xixuan
    Si, Changyu
    Gong, Jianxiao
    Zhou, Huijun
    Gu, Jiale
    Qin, Ailing
    Song, Weijie
    Song, Fangfang
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 1940 - 1949
  • [33] Increased risk of cancers in metabolic dysfunction-associated steatotic liver disease and MetALD
    Park, Yewan
    Jung, Jooyi
    Kim, Gi-Ae
    JOURNAL OF HEPATOLOGY, 2024, 80 : S468 - S468
  • [34] Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Cazac, Georgiana-Diana
    Mihai, Bogdan-Mircea
    Stefanescu, Gabriela
    Gilca-Blanariu, Georgiana-Emmanuela
    Mihai, Catalina
    Grigorescu, Elena-Daniela
    Onofriescu, Alina
    Lacatusu, Cristina-Mihaela
    NUTRIENTS, 2024, 16 (13)
  • [35] Cardiovascular Disease Risk Is Increased In Adolescents With Metabolic Dysfunction-associated Steatotic Liver Disease
    Short, Kevin R.
    Palle, Sirish K.
    Tryggestad, Jeanie B.
    Hellman, Diana A.
    Sciarrillo, Christina M.
    Emerson, Sam R.
    Friedman, Jacob E.
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2024, 56 (10) : 680 - 680
  • [36] Association of psychosocial risk factors and liver transplant evaluation outcomes in metabolic dysfunction-associated steatotic liver disease
    Wang, Roy X.
    Lee, Jason J.
    Mirda, Danielle
    Hao, Jinxuan
    Goebel, Anna M.
    Deutsch-Link, Sasha
    Serper, Marina
    Bittermann, Therese
    LIVER TRANSPLANTATION, 2024, 30 (12)
  • [37] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
    Eskridge, Wayne
    Cryer, Donna R.
    Schattenberg, Joern M.
    Gastaldelli, Amalia
    Malhi, Harmeet
    Allen, Alina M.
    Noureddin, Mazen
    Sanyal, Arun J.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [38] Adherence to the planetary health diet index and metabolic dysfunction-associated steatotic liver disease: a cross-sectional study
    Qiu, Xin
    Shen, Shuang
    Jiang, Nizhen
    Lu, Donghong
    Feng, Yifei
    Yang, Guodong
    Xiang, Bangde
    FRONTIERS IN NUTRITION, 2025, 12
  • [39] Psychosocial risks in metabolic dysfunction-associated steatotic liver disease
    Astrom, Hanne
    Takami Lageborn, Christine
    Hagstrom, Hannes
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 19 (03) : 273 - 290
  • [40] Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Polyzos, Stergios A.
    Targher, Giovanni
    CURRENT OBESITY REPORTS, 2024, 13 (02) : 242 - 255